
Psychobiological Approaches for Anxiety Disorders
Treatment Combination Strategies
Stefan G. Hofmann(Autor*in)
Wiley (Verlag)
Erschienen am 23. März 2012
Buch
Softcover
216 Seiten
978-0-470-97180-2 (ISBN)
Beschreibung
Psychobiological Approaches for Anxiety Disorders presents a comprehensive overview of the latest empirical evidence and research results on combining pharmacological agents and CBT techniques for the treatment of anxiety disorders.
* The first book to focus on the issue of enhancing CBT with pharmacological agents
* Features chapters from leading authors in the fields of psychiatry, pharmacology, clinical psychology, neuroscience, and emotion research
* Contributes significantly to the field by summarizing the contemporary research in combination treatments in anxiety disorders
* A valuable resource for clinicians in training, as well as experienced clinicians seeking to help patients with anxiety disorders
Weitere Details
Reihe
Auflage
1. Auflage
Sprache
Englisch
Verlagsort
Hoboken
Großbritannien
Verlagsgruppe
John Wiley and Sons Ltd
Zielgruppe
Für Beruf und Forschung
Produkt-Hinweis
Broschur/Paperback
Klebebindung
Maße
Höhe: 226 mm
Breite: 150 mm
Dicke: 13 mm
Gewicht
272 gr
ISBN-13
978-0-470-97180-2 (9780470971802)
Schweitzer Klassifikation
Weitere Ausgaben
Andere Ausgaben

E-Book
04/2012
Wiley
39,99 €
Als Download verfügbar

E-Book
03/2012
Wiley-Blackwell
39,99 €
Als Download verfügbar

Buch
03/2012
Wiley
93,90 €
Artikel ist vergriffen; siehe andere Ausgabe
Person
Stefan G. Hofmann is Professor of Psychology at Boston University and the Director of the Psychotherapy and Emotion Research Laboratory. The incoming President of the Association for Behavioral and Cognitive Therapies, he is widely published with more than 200 peer-reviewed journal articles and book chapters, and 10 books, including An Introduction to Modern CBT (2011, Wiley-Blackwell).
Inhalt
About the Contributors vii
About the Editor xi
Introduction 1
Stefan G. Hofmann
Chapter 1 The Biology and Efficacy of Combination Strategies for Anxiety Disorders 5
Keith A. Ganasen and Dan J. Stein
Chapter 2 Benzodiazepines 25
Bridget A. Hearon and Michael W. Otto
Chapter 3 Tricyclic Antidepressants and Monoamine Oxidase Inhibitors 41
Franklin R. Schneier
Chapter 4 Selective Serotonin Reuptake Inhibitors, Reversible Inhibitors of Monoamine Oxidase-A, and Buspirone 61
Borwin Bandelow, Markus Reitt, and Dirk Wedekind
Chapter 5 D-Cycloserine 75
Adam J. Guastella and Gail A. Alvares
Chapter 6 Yohimbine Hydrochloride 91
Samantha G. Farris, Michelle L. Davis, Lindsey B. DeBoer, Jasper A. J. Smits, and Mark B. Powers
Chapter 7 Cortisol 109
Leila Maria Soravia and Dominique J.-F. de Quervain
Chapter 8 Oxytocin 123
Markus Heinrichs, Frances S. Chen, and Gregor Domes
Chapter 9 Dietary Supplements 145
Lindsey B. DeBoer, Michelle L. Davis, Mark B. Powers, and Jasper A. J. Smits
Chapter 10 A Roadmap for the Research and Practice of Combination Strategies 181
Stefan G. Hofmann
Index 195